Medium-dose riboflavin as a prophylactic agent in children with migraine: a preliminary placebo-controlled, randomised, double-blind, cross-over trial.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/20974610
Conclusion of this study
In this group of children with migraine, there is no evidence that 50 mg riboflavin has a prophylactic effect on migraine attacks. We found some evidence that 50 mg riboflavin may have a prophylactic effect on interval headaches that may correspond to mild migraine attacks or tension-type headache attacks in children with migraine.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study